AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 87 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $119,080 | +27.9% | 13,000 | 0.0% | 0.04% | +22.9% |
| Q4 2022 | $93,080 | +43.2% | 13,000 | 0.0% | 0.04% | +25.0% |
| Q3 2022 | $65,000 | +103.1% | 13,000 | 0.0% | 0.03% | +115.4% |
| Q2 2022 | $32,000 | -64.0% | 13,000 | 0.0% | 0.01% | -59.4% |
| Q1 2022 | $89,000 | -15.2% | 13,000 | 0.0% | 0.03% | -11.1% |
| Q4 2021 | $105,000 | -17.3% | 13,000 | 0.0% | 0.04% | -37.9% |
| Q3 2021 | $127,000 | +46.0% | 13,000 | 0.0% | 0.06% | +48.7% |
| Q2 2021 | $87,000 | – | 13,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,498,838 | $22,889,355 | 11.72% |
| Knoll Capital Management, LLC | 500,000 | $4,580,000 | 7.06% |
| GENDELL JEFFREY L | 5,301,914 | $48,565,532 | 4.55% |
| COWEN AND COMPANY, LLC | 3,732,778 | $34,192,246 | 4.02% |
| Tri Locum Partners LP | 1,327,097 | $12,156,209 | 3.70% |
| Samsara BioCapital, LLC | 1,409,409 | $12,910,186 | 2.67% |
| Altium Capital Management LP | 500,000 | $4,580,000 | 2.54% |
| Vivo Capital, LLC | 3,761,438 | $34,454,772 | 2.39% |
| RTW INVESTMENTS, LP | 5,741,939 | $52,596,161 | 1.10% |
| Knott David M Jr | 291,113 | $2,667 | 1.05% |